Human Caucasian hepatocyte carcinoma (HepG2) (Sigma-Aldrich, cat# 85011430) was used for the cytotoxicity experiments. Targeted fractions were assessed for 50% of cytotoxicity (CC50) at concentrations from 200 to 1 μM in triplicate. Cell viability was performed using the MTT assay as described by Crusco et al. (2019).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.